Peptide-Targeted Polyplexes for Aerosol-Mediated Gene Delivery to CD49f-Overexpressing Tumor Lesions in Lung

[1]  D. Schaffert,et al.  Synthesis of Polyethylenimine-Based Nanocarriers for Systemic Tumor Targeting of Nucleic Acids. , 2019, Methods in molecular biology.

[2]  Xiaoyuan Xu,et al.  Peptide SIKVAV-modified chitosan hydrogels promote skin wound healing by accelerating angiogenesis and regulating cytokine secretion. , 2018, American journal of translational research.

[3]  A. Giuliano,et al.  Breast cancer lung metastasis: Molecular biology and therapeutic implications , 2018, Cancer biology & therapy.

[4]  Manfred Ogris,et al.  Multimodal Fluorescence and Bioluminescence Imaging Reveals Transfection Potential of Intratracheally Administered Polyplexes for Breast Cancer Lung Metastases. , 2017, Human gene therapy.

[5]  P. Krebsbach,et al.  The Role of Integrin α6 (CD49f) in Stem Cells: More than a Conserved Biomarker. , 2017, Stem cells and development.

[6]  M. Ogris,et al.  Fluorescence- and computed tomography for assessing the biodistribution of siRNA after intratracheal application in mice. , 2017, International journal of pharmaceutics.

[7]  Susan A Shorter,et al.  The potential of toxin-based drug delivery systems for enhanced nucleic acid therapeutic delivery , 2017, Expert opinion on drug delivery.

[8]  M. Ogris,et al.  Systemic tumor‐targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes , 2017, The journal of gene medicine.

[9]  S. Mousa,et al.  Downregulation of Bmi1 in breast cancer stem cells suppresses tumor growth and proliferation , 2017, Oncotarget.

[10]  Gang Wu,et al.  Integrin α6/Akt/Erk signaling is essential for human breast cancer resistance to radiotherapy , 2016, Scientific Reports.

[11]  TaschauerAlexander,et al.  Up-Scaled Synthesis and Characterization of Nonviral Gene Delivery Particles for Transient In Vitro and In Vivo Transgene Expression. , 2016 .

[12]  R. Wenger,et al.  ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models , 2016, Molecular Cancer.

[13]  J. Blando,et al.  Linneg Sca-1high CD49fhigh prostate cancer cells derived from the Hi-Myc mouse model are tumor-initiating cells with basal-epithelial characteristics and differentiation potential in vitro and in vivo , 2016, Oncotarget.

[14]  P. Kuppen,et al.  Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins , 2016, Biomarkers in cancer.

[15]  M. Ogris,et al.  Up-Scaled Synthesis and Characterization of Nonviral Gene Delivery Particles for Transient In Vitro and In Vivo Transgene Expression. , 2016, Human gene therapy methods.

[16]  Li Yan,et al.  CD49f Acts as an Inflammation Sensor to Regulate Differentiation, Adhesion, and Migration of Human Mesenchymal Stem Cells , 2015, Stem cells.

[17]  Li Li,et al.  The Presence of EpCAM-/CD49f+ Cells in Breast Cancer Is Associated with a Poor Clinical Outcome , 2015, Journal of breast cancer.

[18]  E. Tagliabue,et al.  Aerosol Delivery in the Treatment of Lung Cancer. , 2015, Current cancer drug targets.

[19]  C. Deng,et al.  A critical role of CD29 and CD49f in mediating metastasis for cancer-initiating cells isolated from a Brca1-associated mouse model of breast cancer , 2014, Oncogene.

[20]  K. Howard,et al.  Mucus barrier-triggered disassembly of siRNA nanocarriers. , 2014, Nanoscale.

[21]  Y. Yin,et al.  IKVAV regulates ERK1/2 and Akt signalling pathways in BMMSC population growth and proliferation , 2014, Cell proliferation.

[22]  S. McNeil,et al.  Longitudinal Imaging of Cancer Cell Metastases in Two Preclinical Models: A Correlation of Noninvasive Imaging to Histopathology , 2014, International journal of molecular imaging.

[23]  E. Boscolo,et al.  α6‐Integrin Is Required for the Adhesion and Vasculogenic Potential of Hemangioma Stem Cells , 2014, Stem cells.

[24]  Takahiro Nomoto,et al.  Targeted gene delivery by polyplex micelles with crowded PEG palisade and cRGD moiety for systemic treatment of pancreatic tumors. , 2014, Biomaterials.

[25]  K. Kojima,et al.  CD49fhigh Cells Retain Sphere-Forming and Tumor-Initiating Activities in Human Gastric Tumors , 2013, PloS one.

[26]  H. Nelis,et al.  Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy. , 2013, Nanomedicine.

[27]  B. Tannous,et al.  Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability. , 2013, Analytical chemistry.

[28]  S. Milstien,et al.  Is tail vein injection a relevant breast cancer lung metastasis model? , 2013, Journal of thoracic disease.

[29]  H. Kleinman,et al.  Laminin-111-derived peptides and cancer , 2013, Cell adhesion & migration.

[30]  P. Dasgupta,et al.  CD49f Is an Efficient Marker of Monolayer- and Spheroid Colony-Forming Cells of the Benign and Malignant Human Prostate , 2012, PloS one.

[31]  Leonhard Möckl,et al.  Tuning nanoparticle uptake: live-cell imaging reveals two distinct endocytosis mechanisms mediated by natural and artificial EGFR targeting ligand. , 2012, Nano letters.

[32]  H. Schöler,et al.  CD49f Enhances Multipotency and Maintains Stemness Through the Direct Regulation of OCT4 and SOX2 , 2012, Stem cells.

[33]  A. Levitzki,et al.  PolyIC GE11 polyplex inhibits EGFR‐overexpressing tumors , 2012, IUBMB life.

[34]  S. Shenouda,et al.  Integrin subunits alpha5 and alpha6 regulate cell cycle by modulating the chk1 and Rb/E2F pathways to affect breast cancer metastasis , 2011, Molecular Cancer.

[35]  M. Ogris,et al.  Sustained, high transgene expression in liver with plasmid vectors using optimized promoter‐enhancer combinations , 2011, The journal of gene medicine.

[36]  A. Hochberg,et al.  Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth , 2011, PloS one.

[37]  D. Schaffert,et al.  Disconnecting the yin and yang relation of epidermal growth factor receptor (EGFR)-mediated delivery: a fully synthetic, EGFR-targeted gene transfer system avoiding receptor activation. , 2011, Human gene therapy.

[38]  R. Senekowitsch-Schmidtke,et al.  Epidermal Growth Factor Receptor-targeted 131I-therapy of Liver Cancer Following Systemic Delivery of the Sodium Iodide Symporter Gene. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  R. Senekowitsch-Schmidtke,et al.  Epidermal Growth Factor Receptor-targeted 131I-therapy of Liver Cancer Following Systemic Delivery of the Sodium Iodide Symporter Gene. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  D. Schaffert,et al.  Poly(I:C)-Mediated Tumor Growth Suppression in EGF-Receptor Overexpressing Tumors Using EGF-Polyethylene Glycol-Linear Polyethylenimine as Carrier , 2011, Pharmaceutical Research.

[41]  A. Kraneveld,et al.  A comparison of fixation methods on lung morphology in a murine model of emphysema. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[42]  H. Uramoto,et al.  Clinicopathologic characteristics of mucinous carcinoma of the breast. , 2010, International surgery.

[43]  B. Tannous,et al.  Gaussia luciferase reporter assay for monitoring biological processes in culture and in vivo , 2009, Nature Protocols.

[44]  Kevin Braeckmans,et al.  Extracellular barriers in respiratory gene therapy☆ , 2008, Advanced Drug Delivery Reviews.

[45]  D. Redelman,et al.  The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci , 2007, International journal of experimental pathology.

[46]  M. Juliano,et al.  SIKVAV, a Laminin α1-Derived Peptide, Interacts with Integrins and Increases Protease Activity of a Human Salivary Gland Adenoid Cystic Carcinoma Cell Line through the ERK 1/2 Signaling Pathway , 2007 .

[47]  C. Bräuchle,et al.  Cellular dynamics of EGF receptor-targeted synthetic viruses. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  K. Ulbrich,et al.  Incorporation of a laminin-derived peptide (SIKVAV) on polymer-modified adenovirus permits tumor-specific targeting via α6-integrins , 2007, Cancer Gene Therapy.

[49]  Ernst Wagner,et al.  The internalization route resulting in successful gene expression depends on both cell line and polyethylenimine polyplex type. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[50]  M. A. Egea,et al.  Spectroscopic techniques applied to the study of laminin fragments inserted into model membranes. , 2006, Journal of colloid and interface science.

[51]  E. Kleinerman,et al.  Aerosol gene therapy with PEI: IL-12 eradicates osteosarcoma lung metastases. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  S. Carotta,et al.  Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo , 2001, The journal of gene medicine.

[53]  M. Conese,et al.  Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs , 2000, Gene Therapy.

[54]  H. Kleinman,et al.  A synthetic peptide containing the IKVAV sequence from the A chain of laminin mediates cell attachment, migration, and neurite outgrowth. , 1989, The Journal of biological chemistry.